These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Identification of novel epigenetic markers for clear cell renal cell carcinoma. Dalgin GS; Drever M; Williams T; King T; DeLisi C; Liou LS J Urol; 2008 Sep; 180(3):1126-30. PubMed ID: 18639284 [TBL] [Abstract][Full Text] [Related]
11. Differential protein profiling in renal-cell carcinoma. Shi T; Dong F; Liou LS; Duan ZH; Novick AC; DiDonato JA Mol Carcinog; 2004 May; 40(1):47-61. PubMed ID: 15108329 [TBL] [Abstract][Full Text] [Related]
12. Gene signatures of progression and metastasis in renal cell cancer. Jones J; Otu H; Spentzos D; Kolia S; Inan M; Beecken WD; Fellbaum C; Gu X; Joseph M; Pantuck AJ; Jonas D; Libermann TA Clin Cancer Res; 2005 Aug; 11(16):5730-9. PubMed ID: 16115910 [TBL] [Abstract][Full Text] [Related]
13. In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR. Jung M; Ramankulov A; Roigas J; Johannsen M; Ringsdorf M; Kristiansen G; Jung K BMC Mol Biol; 2007 Jun; 8():47. PubMed ID: 17559644 [TBL] [Abstract][Full Text] [Related]
14. [Identification of prognostic parameters for renal cell carcinoma by cDNA arrays and cell chips]. Moch H; Schraml P; Bubendorf L; Mirlacher M; Kononen J; Gasser T; Mihatsch MJ; Kallioniemi OP; Sauter G Verh Dtsch Ges Pathol; 1999; 83():225-32. PubMed ID: 10714215 [TBL] [Abstract][Full Text] [Related]
15. Antisense intronic non-coding RNA levels correlate to the degree of tumor differentiation in prostate cancer. Reis EM; Nakaya HI; Louro R; Canavez FC; Flatschart AV; Almeida GT; Egidio CM; Paquola AC; Machado AA; Festa F; Yamamoto D; Alvarenga R; da Silva CC; Brito GC; Simon SD; Moreira-Filho CA; Leite KR; Camara-Lopes LH; Campos FS; Gimba E; Vignal GM; El-Dorry H; Sogayar MC; Barcinski MA; da Silva AM; Verjovski-Almeida S Oncogene; 2004 Aug; 23(39):6684-92. PubMed ID: 15221013 [TBL] [Abstract][Full Text] [Related]
16. Identification of CD70 as a diagnostic biomarker for clear cell renal cell carcinoma by gene expression profiling, real-time RT-PCR and immunohistochemistry. Diegmann J; Junker K; Gerstmayer B; Bosio A; Hindermann W; Rosenhahn J; von Eggeling F Eur J Cancer; 2005 Aug; 41(12):1794-801. PubMed ID: 16043348 [TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of renal cell carcinoma: a DNA macroarray analysis. Lovisolo JA; Casati B; Clerici L; Marafante E; Bono AV; Celato N; Salvadore M BJU Int; 2006 Jul; 98(1):205-16. PubMed ID: 16831170 [TBL] [Abstract][Full Text] [Related]
18. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor. Shoji S; Tang XY; Umemura S; Itoh J; Takekoshi S; Shima M; Usui Y; Nagata Y; Uchida T; Osamura RY; Terachi T Eur Urol; 2009 Feb; 55(2):441-9. PubMed ID: 18395325 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer. Tahira AC; Kubrusly MS; Faria MF; Dazzani B; Fonseca RS; Maracaja-Coutinho V; Verjovski-Almeida S; Machado MC; Reis EM Mol Cancer; 2011 Nov; 10():141. PubMed ID: 22078386 [TBL] [Abstract][Full Text] [Related]
20. Detection of transcript for brain-type fatty Acid-binding protein in tumor and urine of patients with renal cell carcinoma. Teratani T; Domoto T; Kuriki K; Kageyama T; Takayama T; Ishikawa A; Ozono S; Nozawa R Urology; 2007 Feb; 69(2):236-40. PubMed ID: 17320655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]